Unravelling the Fate of Coronary Artery Disease in Patients Undergoing Valve Replacement for Severe Aortic Valve Stenosis

Severe aortic valve stenosis is the most frequent pathology in western world and approximately 50% of these patients have concomitant coronary artery disease (CAD). Revascularization proximal obstructive CAD undergoing surgical replacement (SAVR) common practice considered appropriate. However, management with transcatheter implantation (TAVI) more controversial. Nevertheless, performing percutaneous intervention (PCI) significant (>70%) lesions a widely adopted strategy, but robust supporting scientific evidence missing. Some studies suggest that complex incomplete revascularization negatively impacts outcomes post-TAVI. As increasingly younger are TAVI, optimizing long-term will become important. Although PCI TAVI safe, no benefit on has been demonstrated, possibly due to an inadequate selection prognostically important for revascularization. A possible solution might be use physiological indices, their own limitations data needed support widespread adoption. In this review we provide overview current after (AVR) regarding population.